Biovitrum Overview

  • Founded
  • 2001
  • Status
  • Acquired/​Merged
  • Employees
  • 547
  • Latest Deal Type
  • Merger of Eq.

Biovitrum General Information


Provider of pharmaceuticals for common diseases and conditions. The company engages in developing small molecule drugs and recombinant protein therapeutics with focus on metabolic disorders and oncology. The company was spun out of Pharmacia Corporation.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • Lindhagensgatan 100
  • 112 76 Stockholm
  • Sweden
+46 08-697 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biovitrum Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger of Equals 05-Nov-2009 000.00 Completed Generating Revenue
6. PIPE 30-Jun-2009 00.000 000.00 Completed Generating Revenue
5. Secondary Transaction - Private 27-Mar-2009 000.00 000.00 Completed Generating Revenue
4. PIPE 30-Sep-2008 00.000 000.00 Completed Generating Revenue
3. IPO 15-Sep-2006 000.00 000.00 00000 Completed Generating Revenue
2. Early Stage VC 09-Nov-2001 Completed Startup
1. Buyout/LBO 11-Jun-2001 $130M 00000 Completed Startup
To view Biovitrum’s complete valuation and funding history, request access »

Biovitrum Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biovitrum Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AAC Capital PE/Buyout Minority 000 0000 000000 0
Alta Partners Venture Capital Minority 000 0000 000000 0
C WorldWide Asset Management Fondsmaeglerselskab PE-Backed Company Minority 000 0000 000000 0
HBM Partners Venture Capital Minority 000 0000 000000 0
Investor PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Biovitrum Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 22-Aug-2005 000000000000000000 000.00 Pharmaceuticals
Cambridge Biotechnology 21-Mar-2005 Merger/Acquisition Drug Discovery 0000 0000000000
To view Biovitrum’s complete acquisitions history, request access »